Claims
- 1. A phenol derivative of the formula:
- NU--A--X--R.sup.1
- where NU is a bis-phenolic nucleus of the general formula ##STR37## wherein one of R.sup.13 and R.sup.23, and one of R.sup.33 and R.sup.43, has the formula R.sup.3 O--, wherein each R.sup.3, which may be the same or different, is hydrogen or alkyl, cycloalkyl, alkanoyl, alkoxycarbonyl, carboxyalkanoyl or aroyl each of up to 10 carbon atoms, and wherein the other of R.sup.13 and R.sup.23, and the other of R.sup.33 and R.sup.43, is hydrogen;
- wherein R.sup.4 and R.sup.14, which may be the same or different, each is hydrogen or alkyl of up to 5 carbon atoms, or R.sup.4 and R.sup.14 are joined together so that CR.sup.4 --CR.sup.14 is an olefinic double bond;
- wherein R.sup.5 and R.sup.6 together form a direct link or --CH.sub.2 --, --CH(CH.sub.3)--, --CH.sub.2 CH.sub.2 --, --(CH.sub.2).sub.3 -- or --CH.dbd.CH-- and R.sup.15 is hydrogen;
- wherein A is straight- or branched-chain alkylene, alkenylene or alkynylene each of from 4 to 12 carbon atoms; or A has the formula:
- --A.sup.1 --Y.sup.3 --A.sup.21 --
- wherein A.sup.1 is alkylene or alkenylene and A.sup.21 is a direct link or alkylene, alkenylene or cycloalkylene, such that A.sup.1 and A.sup.21 together have a total of 2 to 10 carbon atoms, and Y.sup.3 is phenylene or naphthylene which is unsubstituted or substituted with one or more halogen or methyl or ethyl substituents;
- wherein R.sup.1 is alkyl, alkenyl, cycloalkyl or halogenoalkyl each of up to 10 carbon atoms, phenyl, chlorophenyl, o-ethylphenyl, p-cyanophenyl, p-hydroxyphenyl, p-methoxyphenyl, alkyl of 1 to 3 carbon atoms which bears a phenyl, tolyl, halogenophenyl or trifluoromethylphenyl substituent, .alpha.-methylbenzyl, 3,4-dichlorobenzyl, p-cyanobenzyl or p-methylthiobenzyl, or R.sup.1 is joined to R.sup.2 as defined below; and
- wherein X is --CONR.sup.2 --, --CSNR.sup.2 --, --NR.sup.12 CO-- or --NR.sup.12 CS--, wherein R.sup.2 is hydrogen or alkyl of up to 6 carbon atoms, or R.sup.1 and R.sup.2 together form alkylene such that, with the adjacent nitrogen atom, they form a heterocyclic ring of 5 to 7 ring atoms, one of which may be a second heterocyclic atoms selected from oxygen, sulphur and nitrogen; and
- wherein R.sup.12 is hydrogen or alkyl of up to 6 carbon atoms;
- or a pharmaceutically-acceptable salt of a compound wherein R.sup.3 is carboxyalkanoyl.
- 2. A phenol derivative as claimed in claim 11 wherein R.sup.15, R.sup.23 and R.sup.43 are all hydrogen; wherein R.sup.13 and R.sup.33 both have the formula R.sup.3 O-- wherein R.sup.3 is hydrogen or alkanoyl or alkoxycarbonyl each of up to 5 carbon atoms; wherein either R.sup.4 is hydrogen and R.sup.14 is hydrogen, methyl or ethyl, or R.sup.4 and R.sup.14 are joined together so that CR.sup.4 --CR.sup.14 is an olefinic double bond; wherein R.sup.5 and R.sup.6 together form --CH.sub.2 --, --CH(CH.sub.3)--, --CH.sub.2 CH.sub.2 -- or --CH.dbd.CH--;
- wherein the group --A-- is a straight chain alkylene group of the formula
- --(CH.sub.2).sub.n --
- wherein n is an integer of from 4 to 12 or the group A is a group of the formula:
- --A.sup.1 --Y.sup.3 --A.sup.21 --
- wherein A.sup.1 is straight-chain alkylene of 2 to 9 carbon atoms, Y.sup.3 -- is meta- or para- phenylene and A.sup.< is a direct link, methylene, ethylene, or trimethylene;
- wherein X is --CONR.sup.2 --;
- wherein either R.sup.1 is n-butyl, isobutyl, t-butyl, n-pentyl, isopentyl, t-pentyl, 2,2-dimethylpropyl, 1-methylbutyl, 2-methylbutyl, n-hexyl, 1,1-dimethylbutyl, 1,3-dimethylbutyl, n-heptyl, n-decyl, cyclopentyl, cyclohexyl, phenyl, o-ethylphenyl, p-chlorophenyl, m-chlorophenyl, p-cyanophenyl, p-hydroxyphenyl, p-methoxyphenyl, benzyl, .alpha.-methylbenzyl, p-chlorobenzyl, p-methylbenzyl, 3,4-dichlorobenzyl, p-cyanobenzyl, p-methylthiobenzyl, p-trifluoromethylbenzyl, phenethyl, p-flouorophenethyl, p-chlorophenethyl, 1H,1H,-heptafluorobutyl, 4,4,5,5,5-pentafluoropentyl or 1H,1H,2H,2H,3H,3H-heptaflourohexyl and R.sup.2 is hydrogen, methyl, ethyl or n-butyl, or --NR.sup.1 R.sup.2 is pyrrolidino, piperidino, 4-methylpiperidino, 3-methylpiperidino, morpholino or 4-methylpiperazino.
- 3. A phenol derivative as claimed in claim 1 wherein R.sup.15, R.sup.23 and R.sup.43 are all hydrogen, wherein R.sup.13 and R.sup.33 both have the formula R.sup.3 O-- wherein R.sup.3 is hydrogen, wherein either R.sup.4 is hydrogen and R.sup.14 is hydrogen, methyl or ethyl, or R.sup.4 and R.sup.14 are joined together, wherein R.sup.5 and R.sup.6 together form --CH.sub.2 --, --CH.sub.2 CH.sub.2 --, --CH(CH.sub.3)-- or --CH.dbd.CH--, wherein --A-- is --(CH.sub.2).sub.n --, wherein n is an integer from 4 to 12, or --A-- is ##STR38## wherein p is an integer from 2 to 9, q is 0 to 3, and the --(CH.sub.2).sub.q --group is in the meta- or para-position; wherein R.sup.1 is' alkyl or fluoroalkyl each of 4 to 10 carbon atoms, or phenyl or chlorophenyl, or alkyl of 1 to 3 carbon atoms which bears a phenyl, tolyl, halogenophenyl or trifluoromethylphenyl substituent, or is linked to R.sup.2 as stated below; and
- wherein X is --CONR.sup.2 --, wherein R.sup.2 is hydrogen or alkyl of up to 3 carbon atoms or together with R.sup.1 forms alkylene of 5 or 6 carbon atoms.
- 4. A phenol derivative as claimed in claim 1 wherein the number of carbon atoms in the two groups A and R.sup.1 adds up to 14 to 16 if neither R.sup.1 nor A contains a phenyl or phenylene group, 17 to 19 if there is either a phenylene group in --A-- or a phenyl group in R.sup.1, and 19 to 21 if there are both a phenylene group in --A-- and a phenyl group in R.sup.1.
- 5. A phenol derivative as claimed in claim 1 wherein:
- NU is 6-hydroxy-2-p-hydroxyphenylnaphth-1-yl and A is [--(CH.sub.2)10--, --(CH.sub.2)11--]--(CH.sub.2).sub.10 --, --(CH.sub.2).sub.11 -- or --(CH.sub.2).sub.5 --(1,4-phenylene)--(CH).sub.2 --;
- or NU is (1RS,2RS)- or (1RS,2RS)-1,2,3,4-tetrahydro-6-hydroxy-2-p-hydroxyphenylnaphth[yl]-1-yl (either 1RS, 2RS or 1RS, 2RS isomer), or NU is (1RS,2RS)- or (1RS,2SR)-1,2,3,4-tetrahydro-6-hydroxy-2-p-hydroxy-phenyl-2-methylnaphth-1-yl (either 1RS,[]2RS-, or 1RS,[2RS]2SR-isomer), and A is --(CH.sub.2).sub.10 --, --(CH.sub.2).sub.11 -- or --(CH.sub.2).sub.4 --(1,4-phenylene)--(CH.sub.2).sub.2 --;
- or NU is (1RS, 2[]RS)-5-hydroxy-2-p-hydroxyphenylindan-1-yl or (1RS, 2RS)-5-hydroxy-2-p-hydroxy-phenyl-2-methylindan-1-yl and A is --(CH.sub.2).sub.10 --, --(CH.sub.2).sub.11 -- or --(CH.sub.2).sub.4 --(1,4-phenylene)--(CH.sub.2).sub.2 --; and
- wherein X--R.sup.1 is --CONRa.sup.1 R.sup.2 wherein R.sup.2 is hydrogen or methyl and R.sup.1 is n-butyl, 1H,1H-heptafluorobutyl, n-pentyl or n-hexyl.
- 6. The compound:
- N-n-butyl-, N-n-butyl-N-methyl, N-n-pentyl-, N-(1H,1H-heptafluorobutyl)- or N-(1H,1H-heptafluorobutyl)-N-methyl-3-p-[5-(6-hydroxy-2-p-hydroxyphenylnaphth-1-yl)pentyl]-phenylpropionamide; or
- N-methyl-N-(1H,1H-heptafluorobutyl)-p-{4-[(1RS,2RS)-6-hydroxy-2-p-hydroxyphenyl-2-methyl-1,2,3,4-tetrahydronaphth-1-yl]butyl}phenyl-propionamide.
- 7. A pharmaceutical composition having antioestrogenic activity comprising an effective amount of a phenol derivative, claimed in claim 1, together with a pharmaceutically acceptable diluent or carrier.
- 8. A composition as claimed in claim 7 which contains, in addition to the phenol derivative, an effective amount of one or more antiandrogenic agents or antiprogestational agents.
- 9. A method for producing an antioestrogenic effect in a warm-blooded animal in need of such treatment, which comprises administering to said animal an effective amount of at least one phenol derivative as claimed in claim 1.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8311678 |
Apr 1983 |
GBX |
|
Parent Case Info
This is a division of application Ser. No. 604,964, filed Apr. 27, 1984, now U.S. Pat. No. 4,732,912.
US Referenced Citations (12)
Foreign Referenced Citations (3)
Number |
Date |
Country |
160508 |
Nov 1985 |
EPX |
166509 |
Jan 1986 |
EPX |
1257266 |
Dec 1971 |
GBX |
Non-Patent Literature Citations (1)
Entry |
L. W. Landvatter et al., J. Med. Chem., (1982), pp. 1300-1307. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
604964 |
Apr 1984 |
|